Left Ventricular Mass Index and Relative Wall Thickness Predict Atrial High-Rate Episodes in Patients With Pacemaker

Qin Zhang1, Limin Xiang2, Gege Zhao3

  • 1Department of Cardiology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China.

PubMed

Insights

Atrial high-rate episodes (AHREs) after cardiac device implantation are predicted by echocardiographic indices. Left ventricular mass index (LVMI) and relative wall thickness (RWT) are independent predictors of AHREs, guiding early intervention.

Area of Science:

  • Cardiology
  • Medical Devices
  • Echocardiography

Background:

  • Atrial high-rate episodes (AHREs) post-cardiac implantable electronic device (CIED) implantation are linked to stroke risk.
  • Echocardiographic indices like left ventricular mass index (LVMI) and relative wall thickness (RWT) may predict AHREs.

Purpose of the Study:

  • To investigate the predictive value of LVMI and RWT for AHREs following CIED implantation.
  • To identify echocardiographic predictors of AHREs in patients receiving pacemakers.

Main Methods:

  • Retrospective single-center study of 122 patients undergoing dual-chamber pacemaker implantation.
  • Analysis of clinical data, serological markers, and echocardiographic indices.
  • Cox regression and ROC curve analysis to determine predictors and predictive value of LVMI and RWT for AHREs.

Main Results:

  • Lower RWT and higher LVMI were independently associated with an increased risk of AHREs.
  • ROC analysis indicated predictive values for LVMI (AUC=0.722) and RWT (AUC=0.716).
  • Patients with LVMI ≥ 114.930 or RWT < 0.392 showed a higher incidence of AHREs.

Conclusions:

  • LVMI and RWT are independent predictors of AHREs after pacemaker implantation.
  • Specific thresholds for LVMI (≥ 114.930) and RWT (< 0.392) identify high-risk patients.
  • These findings support early clinical intervention for patients at high risk of AHREs.
Abstract

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
194
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
362
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
380
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
371
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
386